We find that JQ1 suppresses MYC transcription and can synergize with CHEK1 inhibitor prexasertib to suppress tumor growth more effectively than either single agent alone, while prolonging survival in the animals bearing CTDNEP1-deficient MYC-amplified MB tumors. Here, CTDNEP1 is linked to neoplasm.